HUP9800829A3 - Collagen-based methods and formulations for the treatment of immune system-mediated diseases - Google Patents

Collagen-based methods and formulations for the treatment of immune system-mediated diseases

Info

Publication number
HUP9800829A3
HUP9800829A3 HU9800829A HUP9800829A HUP9800829A3 HU P9800829 A3 HUP9800829 A3 HU P9800829A3 HU 9800829 A HU9800829 A HU 9800829A HU P9800829 A HUP9800829 A HU P9800829A HU P9800829 A3 HUP9800829 A3 HU P9800829A3
Authority
HU
Hungary
Prior art keywords
collagen
formulations
treatment
immune system
based methods
Prior art date
Application number
HU9800829A
Other languages
Hungarian (hu)
Original Assignee
Fibrogen Inc South San Francis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrogen Inc South San Francis filed Critical Fibrogen Inc South San Francis
Publication of HUP9800829A2 publication Critical patent/HUP9800829A2/en
Publication of HUP9800829A3 publication Critical patent/HUP9800829A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9800829A 1995-01-10 1996-01-11 Collagen-based methods and formulations for the treatment of immune system-mediated diseases HUP9800829A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37038895A 1995-01-10 1995-01-10

Publications (2)

Publication Number Publication Date
HUP9800829A2 HUP9800829A2 (en) 1998-07-28
HUP9800829A3 true HUP9800829A3 (en) 1999-09-28

Family

ID=23459429

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800829A HUP9800829A3 (en) 1995-01-10 1996-01-11 Collagen-based methods and formulations for the treatment of immune system-mediated diseases

Country Status (10)

Country Link
EP (1) EP0805686A1 (en)
JP (1) JPH10512554A (en)
AU (1) AU4657096A (en)
BR (1) BR9606753A (en)
CA (1) CA2210088A1 (en)
FI (1) FI972929A (en)
HU (1) HUP9800829A3 (en)
MX (1) MX9705198A (en)
NO (1) NO973193L (en)
WO (1) WO1996021458A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
EP0886471A4 (en) * 1996-11-18 2002-07-17 Emisphere Tech Inc Methods and compositions for inducing oral tolerance in mammals
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
DE19804210A1 (en) 1998-02-03 1999-08-12 Biosyn Arzneimittel Gmbh Recombinant mistletoe lectins
CA2339575A1 (en) * 1998-08-10 2000-02-24 James W. Polarek Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
KR102577697B1 (en) * 2019-11-13 2023-09-14 주식회사 나이벡 Peptides for Inflammation Treatment and Wound healing
EP4072608A1 (en) * 2019-12-12 2022-10-19 Instituto de Engenharia Biomédica (INEB) Fetal decellularized nucleus pulposus material and methods for obtaining pharmaceutic compositions to be used in the treatment of intervertebral disc degeneration and back pain
DE102021214899A1 (en) * 2021-12-22 2023-06-22 Gelita Ag Type I collagen peptide for use in therapy
JP7357189B1 (en) * 2022-07-14 2023-10-06 株式会社リナイス Collagen-containing composition derived from fish cartilage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen

Also Published As

Publication number Publication date
FI972929A0 (en) 1997-07-10
FI972929A (en) 1997-09-10
CA2210088A1 (en) 1996-07-18
MX9705198A (en) 1997-12-31
WO1996021458A1 (en) 1996-07-18
EP0805686A1 (en) 1997-11-12
HUP9800829A2 (en) 1998-07-28
NO973193L (en) 1997-09-09
JPH10512554A (en) 1998-12-02
AU4657096A (en) 1996-07-31
NO973193D0 (en) 1997-07-09
BR9606753A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
EP0907369A4 (en) Materials and methods for treatment of plaquing diseases
GR980300033T1 (en) Compositions for the treatment of dermatological disorders and methods for their use
HUP9904665A3 (en) Immune response modifier compounds for treatment of th2 mediated and related diseases
EP0711572A4 (en) Inhalation medicator and method of using the same
HUP9802825A3 (en) Methods and formulations for modulating the human sexual response
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
ZA969217B (en) Skin care preparation and method
HK1043937A1 (en) Human therapeutic uses of bpi protein products
EP0761718A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
EP0761721A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and methods of use thereof
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
EP0761719A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
EP0761720A3 (en) Process for the preparation of poly-o-hydroxyamides and poly-o-mercaptoamides
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
EP0540575A4 (en) Human meg-csf protein and methods
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
EP0862442A4 (en) Methods for diagnosis and treatment of bloom's syndrome
EP0731064A3 (en) Treatment and use of residues from the direct synthesis of organochlor- or chlorsilanes
AU3632899A (en) Method for the therapeutic and prophylactic treatment of dental diseases
AU6404698A (en) Treatment methods for obtaining therapeutic products and resulting products
HUT68145A (en) Procedure for the treatment and shaping of hair
ZA968902B (en) Methods and compositions for treatment of diseases